Stay updated on BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial

Sign up to get notified when there's something new on the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for BMS-986277 with or without nivolumab is displayed, including study design, participant criteria, locations, outcome measures, and supporting documents. The record indicates the study was terminated and is no longer recruiting participants.
    Difference
    64%
    Check dated 2026-11-09T13:23:09.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-02T12:50:41.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates about the transition from using “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-26T14:29:53.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:15:07.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:41:37.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the study details and indicating access is blocked. The error screen presents a minimal layout with navigation to the Home page and a basic site footer.
    Difference
    21%
    Check dated 2026-09-21T20:42:53.000Z thumbnail image

Stay in the know with updates to BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial page.